LESTER R SAUVAGE, MD
Osteopathic Medicine at Minor Ave, Seattle, WA
License number
Washington MD00027752
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
515 Minor Ave SUITE 300, Seattle, WA 98104
Phone
(206) 386-9500
(206) 386-9605 (Fax)
(206) 386-9605 (Fax)
Professional information
Dr. Lester R Sauvage, Seattle WA - MD (Doctor of Medicine)
Specialties:
Geriatric Medicine
Address:
515 Minor Ave STE 300, Seattle 98104
(206) 386-9500 (Phone)
(206) 386-9500 (Phone)
Certifications:
Geriatric Medicine, 1990, Internal Medicine, 1987
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
515 Minor Ave STE 300, Seattle 98104
Overlake Hospital Medical Center
1035 116Th Ave North #East, Bellevue 98004
Overlake Hospital Medical Center
1035 116Th Ave North #East, Bellevue 98004
Education:
Medical School
Saint Louis University School Of Medicine
Graduated: 1983
Med College Wi Affil Hosps
Saint Louis University School Of Medicine
Graduated: 1983
Med College Wi Affil Hosps
Lester Sauvage, Mercer Island WA
Work:
NW. Geriatrics
7707 SE 27Th St, Mercer Island, WA 98040 Minor & James Medical
515 Minor Ave, Seattle, WA 98104
7707 SE 27Th St, Mercer Island, WA 98040 Minor & James Medical
515 Minor Ave, Seattle, WA 98104
Method Of Making Vascular Prosthesis By Perfusion
US Patent:
4911713, Mar 27, 1990
Filed:
Jan 27, 1987
Appl. No.:
7/007369
Inventors:
Lester R. Sauvage - Seattle WA
Svetlana Kaplan - Mountlake Terrace WA
Svetlana Kaplan - Mountlake Terrace WA
International Classification:
A61F 206
US Classification:
623 1
Abstract:
A method of making an impermeable vascular prosthesis is disclosed which comprises the steps of treating a porous textile conduit with a first solution of cross-linking agent; perfusing the conduit with a second solution of cross-linking agent and protein; and drying the perfused conduit to allow gelation in a second solution to form an impermeable vascular prosthesis. Perfusion of the lumen of the prosthesis is performed with sufficient pressure to ensure that all interstices of the porous textile conduit are completely filled. A gelation mixture comprising albumin and glutaraldehyde is preferably utilized for perfusion of the prosthesis. Methods for preserving these grafts indefinitely by treatment with glycerol and other alkyl alcohols are also disclosed.
Method For Reducing Platelet Aggregation
US Patent:
5401730, Mar 28, 1995
Filed:
Apr 22, 1993
Appl. No.:
8/052219
Inventors:
Lester R. Sauvage - Seattle WA
Svetlana Kaplan - Mountlake Terrace WA
Alexander Kaplan - Mountlake Terrace WA
Svetlana Kaplan - Mountlake Terrace WA
Alexander Kaplan - Mountlake Terrace WA
Assignee:
The Hope Heart Institute - Seattle WA
International Classification:
A61K 3160, A61K 31315, A61K 3119
US Classification:
514165
Abstract:
Patients having a predisposition for thrombus formation are effectively treated with compositions of acetylsalicylic acid, citric acid, thiamine and/or a zinc salt. The combination of aspirin and citric acid has been found to be significantly more effective in inhibiting platelet aggregability than aspirin alone, and thiamine contributes to the reduction in thrombotic potential by reducing plasma fibrinogen levels. Accordingly, new methods and compositions are disclosed for reducing the thrombotic potential of human or animal subjects, such as in the prophylaxis or treatment of atherosclerosis, vascular surgery patients or other cardiovascular diseases.